National Institute of Allergy and Infectious Diseases; Notice of Meetings, 69122-69123 [E9-30865]

Download as PDF 69122 Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices Committee Name Tentative Date of Meeting(s) Science Advisory Board to NCTR Advisory Committee 10-Digit Information Line Code November 17–18 3014512559 March, May, July, and November dates to be announced 8732110002 Center for Tobacco Tobacco Products Scientific Advisory Committee Dated: December 24, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–30973 Filed 12–29–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Second Annual Sentinel Initiative Public Workshop AGENCY: Food and Drug Administration, HHS. mstockstill on DSKH9S0YB1PROD with NOTICES ACTION: Notice of public workshop. The Food and Drug Administration (FDA) is announcing the following workshop: Second Annual Sentinel Initiative Public Workshop. This 1-day workshop, organized and hosted by the Engelberg Center for Health Care Reform at Brookings, is supported by a grant from FDA. This workshop is intended to communicate the current status and future vision of active medical product surveillance activities and explore stakeholder perspectives on a broad range of issues. The workshop will feature a series of presentations on recently completed FDA contracts to inform various aspects of the development of the Sentinel System; an update on FDA’s ongoing pilot projects in active surveillance of medical product safety; and a discussion of three issues of broad interest: maintaining patient privacy while conducting medical product safety surveillance, developing the Sentinel System as a national resource for medical product safety surveillance for others outside of FDA, and developing a multi-purpose distributed system that can be used to conduct safety surveillance, comparative effectiveness research, product quality assessment and to address other types of public health questions. Date and Time: The workshop will be held on January 11, 2010, from 8:30 a.m. to 4:45 p.m. VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 Location: The workshop will be held at Marriott Metro Center at 775 12th Street NW., Washington, DC 20005. Contact: Kayla Garvin, Center for Drug Evaluation and Research, Bldg. 22, rm. 4339, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20903, 301– 796–3755, e-mail: Kayla.Garvin@fda.hhs.gov. Registration: To attend the workshop, please register at https://tinyurl.com/ yce6c3z. When registering, provide the following information: Your name, title, company or organization (if applicable), address, phone number, and e-mail address. There is no fee to register for the public workshop and because seating is limited, registration will be on a first-come, first-served basis. A 1-hour lunch break is scheduled; however no food will be provided. There are multiple restaurants within walking distance of the hotel where attendees can purchase lunch. If you need special accommodations due to a disability, please contact Brookings’ event coordinator at 202–797–4391 or by email: sentinelevent@brookings.edu at least 7 days in advance. Transcripts: Please be advised that as soon as a transcript is available, it will be accessible at https://www.fda.gov/ Safety/FDAsSentinelInitiative/ ucm149341.htm. It may be viewed at the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A transcript will also be available in either hardcopy or on CD–ROM, after submission of a Freedom of Information request. Written requests are to be sent to the Division of Freedom of Information (HFI–35), Office of Management Programs, Food and Drug Administration, 5600 Fishers Lane, rm. 6–30, Rockville, MD 20857. Dated: December 23, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–30971 Filed 12–29–09; 8:45 am] BILLING CODE 4160–01–S PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Allergy and Infectious Diseases Council. Date: February 1, 2010. Open: 10:30 a.m. to 11:40 a.m. Agenda: Report from the Institute Director. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Closed: 11:40 a.m. to 12:40 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD E:\FR\FM\30DEN1.SGM 30DEN1 mstockstill on DSKH9S0YB1PROD with NOTICES Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council, Allergy, Immunology and Transplantation Subcommittee. Date: February 1, 2010. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council, Microbiology and Infectious Diseases Subcommittee. Date: February 1, 2010. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council, Acquired Immunodeficiency Syndrome Subcommittee. Date: February 1, 2010. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room A, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Program advisory discussions and reports from division staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 www.niaid.nih.gov/facts/facts.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 22, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–30865 Filed 12–29–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Research Resources Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Research Resources Council. Date: January 26, 2010. Open: 8 a.m. to 12:40 p.m. Agenda: Report of the Director and other Institute staff. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 6, Bethesda, MD 20892. Closed: 1:30 p.m. to adjournment. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 6, Bethesda, MD 20892. Contact Person: Louise E. Ramm, PhD, Deputy Director, National Center for Research Resources, National Institutes of Health, Building 31, Room 3B11, Bethesda, Frm 00063 Fmt 4703 Sfmt 4703 MD 20892, 301–496–6023, louiser@ncrr.nih.gov. Information is also available on the Institute’s/Center’s home page: www.ncrr.nih.gov/newspub/minutes.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333; 93.702, ARRA Related Construction Awards, National Institutes of Health, HHS) Dated: December 22, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–30870 Filed 12–29–09; 8:45 am] BILLING CODE 4140–01–P National Center for Research Resources; Notice of Meeting PO 00000 69123 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Biosensors for Early Cancer Detection and Risk Assessment. Date: March 11–12, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Donald L. Coppock, PhD, Scientific Review Officer, Scientific Review and Logistic Branch, Division of Extramural Activities, NCI, National Institutes of Health, 6116 Executive Blvd., Rm. 7151, Bethesda, MD 20892, 301–451–9385, donald.coppock@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology E:\FR\FM\30DEN1.SGM 30DEN1

Agencies

[Federal Register Volume 74, Number 249 (Wednesday, December 30, 2009)]
[Notices]
[Pages 69122-69123]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30865]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Advisory Allergy and Infectious Diseases Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: February 1, 2010.
    Open: 10:30 a.m. to 11:40 a.m.
    Agenda: Report from the Institute Director.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892.
    Closed: 11:40 a.m. to 12:40 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD

[[Page 69123]]

20892-7610, 301-496-7291, kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council, Allergy, Immunology and Transplantation 
Subcommittee.
    Date: February 1, 2010.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room D, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room D, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council, Microbiology and Infectious Diseases Subcommittee.
    Date: February 1, 2010.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council, Acquired Immunodeficiency Syndrome Subcommittee.
    Date: February 1, 2010.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room A, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Program advisory discussions and reports from division 
staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.
    Information is also available on the Institute's/Center's home 
page: https://www.niaid.nih.gov/facts/facts.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-30865 Filed 12-29-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.